Reevaluating the rules: A new chapter in menopause and long-term health
Major medical organizations have abandoned the rigid "stop at 65" rule for hormone replacement therapy (HRT), allowing for continued use based on individual health and quality of life. The FDA is removing its stringent "black box" …